{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T12:38:00Z","timestamp":1780576680273,"version":"3.54.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T00:00:00Z","timestamp":1623110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T00:00:00Z","timestamp":1623110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Lacosamide (LCM) is the antiepileptic drug approved by the U.S. Food and Drug Administration in 2008 that facilitates slow activation of the voltage-gated sodium channels. Neutropenia and cardiac events including sinus node dysfunction (SND) and atrioventricular block have been previously reported as adverse effects of LCM. To date, there have been no reports of severe agranulocytosis resulting in death associated with LCM. Additionally, there have been no reports of concomitant SND and agranulocytosis after LCM administration. Herein we report the first case of LCM-induced severe SND followed by agranulocytosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>The patient with focal epilepsy was initiated on LCM 100\u00a0mg\/day and the dose was increased to 200\u00a0mg\/day on the 9<jats:sup>th<\/jats:sup> hospital day. Severe SND developed on the 10<jats:sup>th<\/jats:sup> hospital day and LCM was discontinued. Thereafter agranulocytosis appeared on the 11<jats:sup>th<\/jats:sup> hospital day, and the patient died from septic shock on the 15<jats:sup>th<\/jats:sup> hospital day.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This case illustrates the need for careful follow-up of the electrocardiogram and the complete blood cell counts when initiating LCM. Moreover, it should be noticed that various side effects may occur simultaneously in the early period of LCM use, even for a short time and at low dosages.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-021-02253-1","type":"journal-article","created":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T04:03:57Z","timestamp":1623125037000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Lacosamide-induced sinus node dysfunction followed by severe agranulocytosis"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2893-2005","authenticated-orcid":false,"given":"Makoto","family":"Shibata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reona","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chisato","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsumi","family":"Furuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,8]]},"reference":[{"key":"2253_CR1","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1111\/epi.13716","volume":"58","author":"A Strzelczyk","year":"2017","unstructured":"Strzelczyk A, Z\u00f6llner JP, Willems LM, Jost J, Paule E, Schubert-Bast S, et al. Lacosamide in status epilepticus: Systematic review of current evidence. Epilepsia. 2017;58:933\u201350.","journal-title":"Epilepsia"},{"key":"2253_CR2","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1124\/mol.107.039867","volume":"73","author":"AC Errington","year":"2008","unstructured":"Errington AC, St\u00f6hr T, Heers C, Lees G. The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels. Mol Pharmacol. 2008;73:157\u201369.","journal-title":"Mol Pharmacol"},{"key":"2253_CR3","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/14740338.2020.1713089","volume":"19","author":"J Li","year":"2020","unstructured":"Li J, Sun M, Wang X. The adverse-effect profile of lacosamide. Expert Opin Drug Saf. 2020;19:131\u20138.","journal-title":"Expert Opin Drug Saf"},{"key":"2253_CR4","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1528-1167.2012.03407.x","volume":"53","author":"A Husain","year":"2012","unstructured":"Husain A, Chung S, Faught E, Isojarvi J, McShea C, Doty P. Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: results from a Phase III open-label extension trial. Epilepsia. 2012;53:521\u20138.","journal-title":"Epilepsia"},{"key":"2253_CR5","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.eplepsyres.2013.05.002","volume":"106","author":"J Novy","year":"2013","unstructured":"Novy J, Bartolini E, Bell GS, Duncan JS, Sander JW. Long-term retention of lacosamide in a large cohort of people with medically refractory epilepsy: a single centre evaluation. Epilepsy Res. 2013;106:250\u20136.","journal-title":"Epilepsy Res"},{"key":"2253_CR6","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.seizure.2015.07.001","volume":"31","author":"WW Zadeh","year":"2015","unstructured":"Zadeh WW, Escartin A, Byrnes W, Tennigkeit F, Borghs S, Li T, et al. Efficacy and safety of lacosamide as first add-on or later adjunctive treatment for uncontrolled partial-onset seizures: a multicentre open-label trial. Seizure. 2015;31:72\u20139.","journal-title":"Seizure"},{"key":"2253_CR7","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.seizure.2017.09.019","volume":"52","author":"SS Welsh","year":"2017","unstructured":"Welsh SS, Lin N, Topjian AA, Abend NS. Safety of intravenous lacosamide in critically ill children. Seizure. 2017;52:76\u201380.","journal-title":"Seizure"},{"key":"2253_CR8","doi-asserted-by":"publisher","first-page":"496","DOI":"10.4103\/IJPSYM.IJPSYM_16_18","volume":"40","author":"NP Rao","year":"2018","unstructured":"Rao NP, Sheth S, Varambally S. Lacosamide Precipitated neutropenia in a patient with bipolar disorder and comorbid epilepsy. Indian J Psychol Med. 2018;40:496\u20137.","journal-title":"Indian J Psychol Med"},{"key":"2253_CR9","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1111\/epi.12108","volume":"54","author":"S Chinnasami","year":"2013","unstructured":"Chinnasami S, Rathore C, Duncan JS. Sinus node dysfunction: an adverse effect of lacosamide. Epilepsia. 2013;54:e90\u20133.","journal-title":"Epilepsia"},{"key":"2253_CR10","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1111\/j.1528-1167.2011.03212.x","volume":"52","author":"A Nizam","year":"2011","unstructured":"Nizam A, Mylavarapu K, Thomas D, Briskin K, Wu B, Saluja D, et al. Lacosamide-induced second-degree atrioventricular block in a patient with partial epilepsy. Epilepsia. 2011;52:e153\u20135.","journal-title":"Epilepsia"},{"issue":"4","key":"2253_CR11","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.yebeh.2011.02.006","volume":"20","author":"LU Krause","year":"2011","unstructured":"Krause LU, Brodowski KO, Kellinghaus C. Atrioventricular block following lacosamide intoxication. Epilepsy Behav. 2011;20(4):725\u20137.","journal-title":"Epilepsy Behav"},{"issue":"6","key":"2253_CR12","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.chest.2016.08.1460","volume":"150","author":"S Gupta","year":"2016","unstructured":"Gupta S, Sakhuja A, Kumar G, McGrath E, Nanchal RS, Kashani KB. Culture-negative severe sepsis: nationwide trends and outcomes. Chest. 2016;150(6):1251\u20139.","journal-title":"Chest"},{"key":"2253_CR13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239\u201345.","journal-title":"Clin Pharmacol Ther"},{"key":"2253_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/MOH.0b013e3282f15fb9","volume":"15","author":"E Andr\u00e8s","year":"2008","unstructured":"Andr\u00e8s E, Maloisel F. Idiosyncratic drug-induced agranulocytosis or acute neutropenia. Curr Opin Hematol. 2008;15:15\u201321.","journal-title":"Curr Opin Hematol"},{"key":"2253_CR15","doi-asserted-by":"publisher","first-page":"657","DOI":"10.7326\/0003-4819-146-9-200705010-00009","volume":"146","author":"F Andersohn","year":"2007","unstructured":"Andersohn F, Konzen C, Garbe E. Systematic review: agranulocytosis induced by nonchemotherapy drugs. Ann Intern Med. 2007;146:657\u201365.","journal-title":"Ann Intern Med"},{"key":"2253_CR16","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1001\/archinte.165.8.869","volume":"165","author":"L Ib\u00e1\u00f1ez","year":"2005","unstructured":"Ib\u00e1\u00f1ez L, Vidal X, Ballar\u00edn E, Laporte JR. Population-based drug-induced agranulocytosis. Arch Intern Med. 2005;165:869\u201374.","journal-title":"Arch Intern Med"},{"key":"2253_CR17","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/S1474-4422(12)70153-9","volume":"11","author":"P Perucca","year":"2012","unstructured":"Perucca P, Gilliam FG. Adverse effects of antiepileptic drugs. Lancet Neurol. 2012;11:792\u2013802.","journal-title":"Lancet Neurol"},{"key":"2253_CR18","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/ajh.10295","volume":"72","author":"TP van Staa","year":"2003","unstructured":"van Staa TP, Boulton F, Cooper C, Hagenbeek A, Inskip H, Leufkens HG. Neutropenia and agranulocytosis in England and Wales: incidence and risk factors. Am J Hematol. 2003;72:248\u201354.","journal-title":"Am J Hematol"},{"issue":"7","key":"2253_CR19","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1111\/j.1528-1167.2007.01188.x","volume":"48","author":"E Ben-Menachem","year":"2007","unstructured":"Ben-Menachem E, Biton V, Jatuzis D, Abou-Khalil B, Doty P, Rudd GD. Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures. Epilepsia. 2007;48(7):1308\u201317.","journal-title":"Epilepsia"},{"issue":"4","key":"2253_CR20","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/j.1528-1167.2006.00509.x","volume":"47","author":"JW Britton","year":"2006","unstructured":"Britton JW, Ghearing GR, Benarroch EE, Cascino GD. The ictal bradycardia syndrome: localization and lateralization. Epilepsia. 2006;47(4):737\u201344.","journal-title":"Epilepsia"},{"issue":"1","key":"2253_CR21","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/trf.13333","volume":"56","author":"B Hauck-Dlimi","year":"2016","unstructured":"Hauck-Dlimi B, Ruppel R, Zimmermann R, Strobel J, Reil A, Eckstein R, et al. Transfusion-related alloimmune neutropenia with no pulmonary complications: one donor-five cases. Transfusion. 2016;56(1):84\u201390.","journal-title":"Transfusion"},{"issue":"3","key":"2253_CR22","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s13318-019-00601-8","volume":"45","author":"L Schultz","year":"2020","unstructured":"Schultz L, Mahmoud SH. Is therapeutic drug monitoring of lacosamide needed in patients with seizures and epilepsy? Eur J Drug Metab Pharmacokinet. 2020;45(3):315\u201349.","journal-title":"Eur J Drug Metab Pharmacokinet"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-021-02253-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-021-02253-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-021-02253-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T04:04:31Z","timestamp":1623125071000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-021-02253-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,8]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2253"],"URL":"https:\/\/doi.org\/10.1186\/s12883-021-02253-1","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,8]]},"assertion":[{"value":"21 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s family for publication of this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"217"}}